Home COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution
Article Open Access

COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution

  • Zhuo Yu , Gang Wang , Emanuel Goldman , Barbara Zangerl , Ning Xie , Yanhong Cao , Jingyu Chen , Sara W. Day , Scott C. Howard , Marcello Maida , Kunal Ray , Monica M. Jablonski , Jiafu Ji , Arnold Postlethwaite , Weikuan Gu EMAIL logo , Dianjun Sun EMAIL logo and Lotfi Aleya EMAIL logo
Published/Copyright: January 11, 2021

Abstract

While countries are in a hurry to obtain SARS-CoV-2 vaccine, we are concerned with the availability of vaccine and whether a vaccine will be available to all in need. We predicted three possible scenarios for vaccine distributions and urge an international united action on the worldwide equitable access. In case the international community does not reach a consensus on how to distribute the vaccine to achieve worldwide equitable access, we call for a distribution plan that includes the employees in international transportation industries and international travelers to halt the disease transmission and promote the recovery of the global economy.

We are glad to see “the joint appeal” by 3,000 people and the comment on the journal [1,2]. We all appreciate the effort of United Nation on mobilizing $28 billion needed to secure vaccines for all [3]. However, we are concerned about the challenge in the production as well as in the capability of distribution of the vaccine in time. While the world is hoping the availability of a vaccine by the end of the year and optimistic about vaccine for all, there are many obstacles in the timely distribution and equal availability to all in the world. Additionally, the anticipated increase in respiratory diseases with winter approaching in the northern hemisphere leads to serious concerns whether a vaccine will be available to all in time [4,5,6,7].

Even under the assumption that a COVID-19 vaccine will become available in time, prioritization regarding its distribution to 195 countries and maintenance of worldwide equitable access will remain challenging [8]. Notably a few countries, including China and the US, are predicted to have the best chance and greatest resources to produce the vaccine and, thus, are most likely to have access to immediate distribution. This implies that worldwide equitable access will not be accomplished if the supply of an approved SARS-CoV-2 vaccine is inadequate [9,10], leading to three possible scenarios. First, the vaccine may only be produced and distributed in the country of origin with possible distribution to a few countries that have close ties with the vaccine-producing country. In the second scenario, the vaccine is successfully developed and produced in several countries at approximately the same time and distributed in those countries, again, possibly including additional countries with close ties. The third scenario assumes that the vaccine is first produced in one or several countries, but the vaccine is supplied worldwide on the basis of the most pressing need. In Table 1, we summarized the impact of these different usages of the SARS-CoV-2 vaccine.

Table 1

Impact of different usages of vaccine

Types of effects Scenario 1 Scenario 2 Scenario 3
Vaccine production One country A few countries One or a few countries
Vaccine usage One country or closely related countries A few countries or closely related countries Prioritized all over the world and first used in urgent places
Immediate benefit for disease control Under control in one country or closely related Under control in a few countries or closely related Stopping international spreading
Ultimate benefit for disease control Under control in one country or closely related Under control in a few countries or closely related Under control over the world
Immediate benefit for economy Back to normal in one country or closely related Back to normal in in a few countries or closely related Back to normal for international business
Ultimate benefit for economy World economy develops slowly because of pandemic in rest of the world World economy develops slowly because of pandemic in other countries Enhance the world economy to develop fast
Impact for future disease control No benefit or action upon individual country No benefit or action upon individual country or a few countries together United international action

To promote any collaborative framework discussing prioritization in access and distribution of the vaccine, it is imperative to understand that COVID-19 is an equal threat to all human societies and cannot be contained unless globally controlled. SARS-CoV-2 has demonstrated more resilient transmission capability than other viruses associated with respiratory diseases causing a single infected individual to precipitate a COVID-19 pandemic in a very short period of time [11,12,13,14].

We as an international group of scientists call upon the world leaders to act together and develop a plan for worldwide distribution of a vaccine as opposed to multiple plans for individual countries. It is imperative that the public and government leaders understand that no single country is capable of stopping the pandemic individually and safeguard its inhabitants from repeated outbreaks, but a united front can achieve a global solution to the pandemic and, thus, prompt the recovery of the world economy.

Most importantly, the successful distribution of the vaccine in one or a few countries will not stop the pandemic and will not recover global economy (Table 1) [15,16]. It will also be a tremendous challenge to vaccinate a majority of the population in a short period of time in large countries, such as China or the US, with populations of 1.4 billion and 0.3 billion, respectively. Even if one or a few countries achieve widespread vaccination success, other factors will remain to halt the potential recovery of an economy hugely dependent on international trade [17]. Additionally, the tourism industry will not recover. Strict testing and isolation measures upon arrival would greatly reduce the number of international travelers [18,19]. This will include the number of people traveling to other countries for tourism or business, which must be greatly reduced or prohibited altogether under this vaccine distribution model. Consequently, neither tourism nor aviation industries can resume sustainable operations if the control of the epidemic remains restricted in a single or few countries [20,21].

Based on reasons mentioned above and that will be described in the subsequent paragraphs, we urge the following steps to accomplish equitable vaccine access: (1) international community to immediately start the discussion on how to form an organized approach to equitable distribution, (2) develop a vaccine distribution plan based on prioritization of needs, and (3) organize and carefully coordinate global distribution.

However, in case the international community does not reach a consensus on how to distribute the vaccine to achieve worldwide equitable access, at a minimum we call for a distribution plan that includes essential people for stopping disease transmission and promoting the recovery of the global economy [10]. Here we propose to vaccinate the employees in international transportation industries and international travelers. We recommend employees in the international transportation industries as the first priority for the vaccination, including international civilian aviation industry, global air freight industry, and global seaborne container trade industry [13,14,22]. These people are essential for the international business as well as for stopping international transmission of SARS-CoV-2. The total number of employees in these three groups are approximately 17 million (Figure 1).

Figure 1 
            Prioritized groups and their population sizes for vaccination.
Figure 1

Prioritized groups and their population sizes for vaccination.

Based on the Aviation Benefits Report of International Air Transport Association [23], around 10.2 million people work in the aviation industry directly, including 2.7 million working as flight and cabin crews, executives, ground services, check-in, training, and maintenance staff; and 5.6 million working for retail, car rental, customs and immigration, freight forwarders, and catering [24].

Based on the source of Wikipedia, in 2019, the world’s three biggest international air cargo companies have a total of 1,261,000 employees (FedEx 400,000; UPS 482,100; DHL 380,000) [25]. If we assume other companies contribute about 50%, the estimated number of employees in the global air freight industry is approximately 2,500,000.

Based on the reports from the World Shipping Council, the total number of direct jobs in the shipping industry is 4.2 million [26].

Second, we recommend all international travelers receive the vaccine. Based on the world air transport statistics 2019 [27], in 2018, the total number of carried air passengers was 4,377,670,000, comprising 1,811,324,000 international passengers and 2,566,346,000 domestic passengers, increasing to over 4.5 billion passengers in 2019. However, this includes “frequent flyers,” equating to 6.5 flights per year taken by an average traveler [28]. Similarly, the Institut de Publique Sondage d'Opinion Secteur (IPSOS) report cites an average of 4.8 trips per airline traveler in 2015 [29,30]. Accordingly, the actual number of international travelers is about 400,000,000 per year. Thus, approximately 30 million people can be expected to travel internationally each month (Figure 1).

We also propose to vaccinate all people working in indirect service, such as airport hotels and restaurants for the four prioritized groups, adding a population of similar size as the total number of people in the prioritized groups [23,30].

It is important to note that the total number of people in the first three priority categories is less than 20 million. This is less than half of the people of a middle-sized country and a small portion of the total population of China or the US. Vaccination of such a count of people in China, the US or any other country will not halt the pandemic of COVID-19 and will not improve the international business and transportation. Thus, neither the stopping of COVID-19 disease nor the economy will be improved by vaccination of these individual in a country. However, if these people in international transportation are vaccinated as we proposed, the international COVID-19 transmission will be greatly halted, and the world economy will be greatly benefited. Most importantly, as long as the world is united for it, it is realistically feasible to support such an approach and produce a globally and individually much more beneficial effect than prioritizing the complete or partial vaccination of people in a single or few countries.

In conclusion, we strongly urge the international community, especially the WHO, regardless of the other considerations regarding the distribution of a potential COVID-19 vaccine, to allow the worldwide distribution of the vaccine to at least the presented priority groups and make every effort including price adjustment, shipment, resource supplement, and personal training to accomplish this target. By doing so, the world economy can begin to recover and the international spreading of the disease will be largely halted. With regard to air passengers, if vaccination becomes mandatory for travelers and the vaccine is available to them, we will be able to achieve effective infection control and regain a functional global and local economy.

This article serves as a call to the public and the leaders of the world to support such an international collaboration and put the health of all humans and world economy in front of individual short-term gain.


These two authors contributed to this manuscript equally.

tel: +1-901-448-2259
tel: +86-451-8661-2695
tel: +03-81-66-57-64

  1. Author contributions: Conceived and designed the experiments: G. W., Z. Y., W. G., D. S., L. A. Performed data searching and collection: N. X., W. G. Analyzed the data: All Authors. Contributed analysis tools: W. G., D. S., L. A. Wrote the manuscript: All Authors. Revise and approve and manuscript: All authors.

  2. Funding: This work was partially supported by funding from merit grant I01 BX000671 to WG from the Department of Veterans Affairs and the Veterans Administration Medical Center in Memphis, TN, USA.

  3. Conflict of interest: The authors declare no competing financial interests.

  4. Availability of data and materials: All the data are available at the public databases as provided in the manuscript.

References

[1] Vaccine Common Good. Declare COVID-19 vaccine a global common good now; 2020. https://vaccinecommongood.org. Accessed 28th Jun 2020.Search in Google Scholar

[2] Yunus M, Donaldson C, Perron JL. COVID-19 vaccines a global common good. Lancet Health Longev. 2020 Oct 1;1(1):e6–8. 10.1016/S2666-7568(20)30003-9.Search in Google Scholar

[3] UN News. COVID-19: right decisions now will secure a life of dignity for all. https://news.un.org/en/story/2020/12/1079292.Search in Google Scholar

[4] Bar-Zeev N, Inglesby T. COVID-19 vaccines: early success and remaining challenges. Lancet. 2020 Sep 3;396:868–9. 10.1016/S0140-6736(20)31867-5.Search in Google Scholar

[5] Keech C, Albert G, Cho I, Robertson A, Reed P, Neal S, et al. Phase 1–2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine. N Engl J Med. 2020 Sep 2;383:2320–32. 10.1056/NEJMoa2026920.Search in Google Scholar

[6] Mckinsey & Company. On pins and needles: will COVID-19 vaccines ‘save the world’? https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/on-pins-and-needles-will-covid-19-vaccines-save-the-world.Search in Google Scholar

[7] Clnet. Coronavirus vaccine: Pfizer, Moderna and how many vaccine doses are coming in 2020. https://www.cnet.com/how-to/coronavirus-vaccine-whats-happening-now-and-everything-you-need-to-know/.Search in Google Scholar

[8] World Health Organization. 172 countries and multiple candidate vaccines engaged in COVID-19 vaccine global access facility. https://www.who.int/news-room/detail/24-08-2020-172-countries-and-multiple-candidate-vaccines-engaged-in-covid-19-vaccine-global-access-facility.Search in Google Scholar

[9] Phelan AL, Eccleston-Turner M, Rourke M, Maleche A, Wang C. Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access. Lancet. 2020 Sep 7;396:800–2. 10.1016/S0140-6736(20)31873-0.Search in Google Scholar

[10] Persad G, Peek ME, Emanuel EJ. Fairly prioritizing groups for access to COVID-19 vaccines. JAMA. 2020 Sep 10;324:1601–2. 10.1001/jama.2020.18513.Search in Google Scholar

[11] Mohapatra RK, Pintilie L, Kandi V, Sarangi AK, Das D, Sahu R, et al. The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy. Chem Biol Drug Des. 2020 Jul 26;96:1187–208. 10.1111/cbdd.13761.Search in Google Scholar

[12] The Wall Street Journal. How many people might one person with coronavirus infect? By Jo Craven McGinty. https://www.wsj.com/articles/how-many-people-might-one-person-with-coronavirus-infect-11581676200.Search in Google Scholar

[13] Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382:1199–207. PMID: 31995857.10.1056/NEJMoa2001316Search in Google Scholar

[14] Böhmer MM, Buchholz U, Corman VM, Hoch M, Katz K, Marosevic DV, et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series. Lancet Infect Dis. 2020 Aug;20(8):920–8. 10.1016/S1473-3099(20)30314-5.Search in Google Scholar

[15] U.S. News. Study: countries must work together to fight coronavirus. By Trevor Bach, contributor. Aug. 18, 2020. https://www.usnews.com/news/best-countries/articles/2020-08-18/countries-must-better-coordinate-actions-to-fight-coronavirus-study-shows.Search in Google Scholar

[16] Fauci AS, Lane HC, Redfield RR. Covid-19 – navigating the uncharted editor. N Engl J Med. 2020 Mar 26;382(13):1268–9. 10.1056/NEJMe2002387, Epub 2020 Feb 28.Search in Google Scholar PubMed PubMed Central

[17] Sharma P, Leung TY, Kingshott RPJ, Davcik NS, Cardinali S. Managing uncertainty during a global pandemic: an international business perspective. J Bus Res. 2020 Aug;116:188–92.10.1016/j.jbusres.2020.05.026Search in Google Scholar PubMed PubMed Central

[18] Fong LHN, Law R, Ye BH. Outlook of tourism recovery amid an epidemic: importance of outbreak control by the government. Ann Tour Res. 2020 May 25;102951. 10.1016/j.annals.2020.102951.Search in Google Scholar

[19] MeKinsey & Company. Reimagining the $9 trillion tourism economy – what will it take? By Margaux Constantin, Steve Saxon, and Jackey Yu. August 5, 2020. https://www.mckinsey.com/industries/travel-logistics-and-transport-infrastructure/our-insights/reimagining-the-9-trillion-tourism-economy-what-will-it-take.Search in Google Scholar

[20] Scudellari M. How the pandemic might play out in 2021 and beyond. Nature. 2020 Aug 5;584(7819):22–5. 10.1038/d41586-020-02278-5.Search in Google Scholar

[21] Suau-Sanchez P, Voltes-Dorta A, Cugueró-Escofet N. An early assessment of the impact of COVID-19 on air transport: just another crisis or the end of aviation as we know it? J Transp Geogr. 2020 Jun;86:102749. 10.1016/j.jtrangeo.2020.102749.Search in Google Scholar

[22] Lee K, Worsnop CZ, Grépin KA, Kamradt-Scott A. Global coordination on cross-border travel and trade measures crucial to COVID-19 response. Lancet. 2020 May 23;395(10237):1593–5. 10.1016/S0140-6736(20)31032-1.Search in Google Scholar

[23] Aviation Benefits Report; 2019. https://www.icao.int/sustainability/Documents/AVIATION-BENEFITS-2019-web.pdf.Search in Google Scholar

[24] Aviation Benefits Beyond Borders. https://aviationbenefits.org/economic-growth/supporting-employment/#:∼:text=Around%2010.2%20million%20people%20work%20in%20the%20aviation%20industry%20directly.Search in Google Scholar

[25] Wikipedia. Cargo Airline. https://en.wikipedia.org/wiki/Cargo_airline.Search in Google Scholar

[26] World Shipping Council. http://www.worldshipping.org/benefits-of-liner-shipping/global-economic-engine.Search in Google Scholar

[27] Statista. Air Transportation-statistics & facts. By E. Mazareanu; 2020 Nov 27. https://www.statista.com/topics/1707/air-transportation/#:∼:text=The%20number%20of%20international%20tourist,the%20progress%20of%20world%20trade.Search in Google Scholar

[28] Travelbulletin. 2018. Issue No 2,076. https://travelbulletin.co.uk/aaccpp/_images/DigitalMagDownload/TB14-09-2018Final.pdf.Search in Google Scholar

[29] Mazareanu E. Air transportation – statistics & facts. Transportation & logistics›aviation; 2020 Mar 4. https://www.statista.com/topics/1707/air-transportation/#:∼:text=Commercial%20airlines%20carried%20more%20than,in%20global%20revenue%20in%202020.Search in Google Scholar

[30] Status of Air Travel in the USA. Online publication: https://www.airlines.org/wp-content/uploads/2016/04/2016Survey.pdf.Search in Google Scholar

Received: 2020-12-18
Accepted: 2020-12-21
Published Online: 2021-01-11

© 2021 Zhuo Yu et al., published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Research Articles
  2. Identification of ZG16B as a prognostic biomarker in breast cancer
  3. Behçet’s disease with latent Mycobacterium tuberculosis infection
  4. Erratum
  5. Erratum to “Suffering from Cerebral Small Vessel Disease with and without Metabolic Syndrome”
  6. Research Articles
  7. GPR37 promotes the malignancy of lung adenocarcinoma via TGF-β/Smad pathway
  8. Expression and role of ABIN1 in sepsis: In vitro and in vivo studies
  9. Additional baricitinib loading dose improves clinical outcome in COVID-19
  10. The co-treatment of rosuvastatin with dapagliflozin synergistically inhibited apoptosis via activating the PI3K/AKt/mTOR signaling pathway in myocardial ischemia/reperfusion injury rats
  11. SLC12A8 plays a key role in bladder cancer progression and EMT
  12. LncRNA ATXN8OS enhances tamoxifen resistance in breast cancer
  13. Case Report
  14. Serratia marcescens as a cause of unfavorable outcome in the twin pregnancy
  15. Spleno-adrenal fusion mimicking an adrenal metastasis of a renal cell carcinoma: A case report and embryological background
  16. Research Articles
  17. TRIM25 contributes to the malignancy of acute myeloid leukemia and is negatively regulated by microRNA-137
  18. CircRNA circ_0004370 promotes cell proliferation, migration, and invasion and inhibits cell apoptosis of esophageal cancer via miR-1301-3p/COL1A1 axis
  19. LncRNA XIST regulates atherosclerosis progression in ox-LDL-induced HUVECs
  20. Potential role of IFN-γ and IL-5 in sepsis prediction of preterm neonates
  21. Rapid Communication
  22. COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution
  23. Case Report
  24. Rare squamous cell carcinoma of the kidney with concurrent xanthogranulomatous pyelonephritis: A case report and review of the literature
  25. An infertile female delivered a baby after removal of primary renal carcinoid tumor
  26. Research Articles
  27. Hypertension, BMI, and cardiovascular and cerebrovascular diseases
  28. Case Report
  29. Coexistence of bilateral macular edema and pale optic disc in the patient with Cohen syndrome
  30. Research Articles
  31. Correlation between kinematic sagittal parameters of the cervical lordosis or head posture and disc degeneration in patients with posterior neck pain
  32. Review Articles
  33. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database
  34. Research Articles
  35. Thermography in the diagnosis of carpal tunnel syndrome
  36. Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis
  37. Comparison of single and double autologous stem cell transplantation in multiple myeloma patients
  38. The influence of smoking in minimally invasive spinal fusion surgery
  39. Impact of body mass index on left atrial dimension in HOCM patients
  40. Expression and clinical significance of CMTM1 in hepatocellular carcinoma
  41. miR-142-5p promotes cervical cancer progression by targeting LMX1A through Wnt/β-catenin pathway
  42. Comparison of multiple flatfoot indicators in 5–8-year-old children
  43. Early MRI imaging and follow-up study in cerebral amyloid angiopathy
  44. Intestinal fatty acid-binding protein as a biomarker for the diagnosis of strangulated intestinal obstruction: A meta-analysis
  45. miR-128-3p inhibits apoptosis and inflammation in LPS-induced sepsis by targeting TGFBR2
  46. Dynamic perfusion CT – A promising tool to diagnose pancreatic ductal adenocarcinoma
  47. Biomechanical evaluation of self-cinching stitch techniques in rotator cuff repair: The single-loop and double-loop knot stitches
  48. Review Articles
  49. The ambiguous role of mannose-binding lectin (MBL) in human immunity
  50. Case Report
  51. Membranous nephropathy with pulmonary cryptococcosis with improved 1-year follow-up results: A case report
  52. Fertility problems in males carrying an inversion of chromosome 10
  53. Acute myeloid leukemia with leukemic pleural effusion and high levels of pleural adenosine deaminase: A case report and review of literature
  54. Metastatic renal Ewing’s sarcoma in adult woman: Case report and review of the literature
  55. Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: Two cases reports and literature review
  56. Skull hemophilia pseudotumor: A case report
  57. Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
  58. Adult-onset citrullinaemia type II with liver cirrhosis: A rare cause of hyperammonaemia
  59. Clinicopathologic features of Good’s syndrome: Two cases and literature review
  60. Fatal immune-related hepatitis with intrahepatic cholestasis and pneumonia associated with camrelizumab: A case report and literature review
  61. Research Articles
  62. Effects of hydroxyethyl starch and gelatin on the risk of acute kidney injury following orthotopic liver transplantation: A multicenter retrospective comparative clinical study
  63. Significance of nucleic acid positive anal swab in COVID-19 patients
  64. circAPLP2 promotes colorectal cancer progression by upregulating HELLS by targeting miR-335-5p
  65. Ratios between circulating myeloid cells and lymphocytes are associated with mortality in severe COVID-19 patients
  66. Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
  67. Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China
  68. Surgical myocardial revascularization outcomes in Kawasaki disease: systematic review and meta-analysis
  69. Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
  70. FGF16 regulated by miR-520b enhances the cell proliferation of lung cancer
  71. Platelet-rich fibrin: Basics of biological actions and protocol modifications
  72. Accurate diagnosis of prostate cancer using logistic regression
  73. miR-377 inhibition enhances the survival of trophoblast cells via upregulation of FNDC5 in gestational diabetes mellitus
  74. Prognostic significance of TRIM28 expression in patients with breast carcinoma
  75. Integrative bioinformatics analysis of KPNA2 in six major human cancers
  76. Exosomal-mediated transfer of OIP5-AS1 enhanced cell chemoresistance to trastuzumab in breast cancer via up-regulating HMGB3 by sponging miR-381-3p
  77. A four-lncRNA signature for predicting prognosis of recurrence patients with gastric cancer
  78. Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: Circulating RNAs could explain atherosclerosis disease progression
  79. Propofol postpones colorectal cancer development through circ_0026344/miR-645/Akt/mTOR signal pathway
  80. Knockdown of lncRNA TapSAKI alleviates LPS-induced injury in HK-2 cells through the miR-205/IRF3 pathway
  81. COVID-19 severity in relation to sociodemographics and vitamin D use
  82. Clinical analysis of 11 cases of nocardiosis
  83. Cis-regulatory elements in conserved non-coding sequences of nuclear receptor genes indicate for crosstalk between endocrine systems
  84. Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
  85. Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens
  86. Relation between IL-8 level and obstructive sleep apnea syndrome
  87. circAGFG1 sponges miR-28-5p to promote non-small-cell lung cancer progression through modulating HIF-1α level
  88. Nomogram prediction model for renal anaemia in IgA nephropathy patients
  89. Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
  90. NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
  91. A nomogram for predicting metabolic steatohepatitis: The combination of NAMPT, RALGDS, GADD45B, FOSL2, RTP3, and RASD1
  92. Clinical and prognostic features of MMP-2 and VEGF in AEG patients
  93. The value of miR-510 in the prognosis and development of colon cancer
  94. Functional implications of PABPC1 in the development of ovarian cancer
  95. Prognostic value of preoperative inflammation-based predictors in patients with bladder carcinoma after radical cystectomy
  96. Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
  97. Prediction of improvement after anterior cruciate ligament reconstruction
  98. Effluent Osteopontin levels reflect the peritoneal solute transport rate
  99. circ_0038467 promotes PM2.5-induced bronchial epithelial cell dysfunction
  100. Significance of miR-141 and miR-340 in cervical squamous cell carcinoma
  101. Association between hair cortisol concentration and metabolic syndrome
  102. Microvessel density as a prognostic indicator of prostate cancer: A systematic review and meta-analysis
  103. Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
  104. Knee alterations in rheumatoid arthritis: Comparison of US and MRI
  105. Long non-coding RNA TUG1 aggravates cerebral ischemia and reperfusion injury by sponging miR-493-3p/miR-410-3p
  106. lncRNA MALAT1 regulated ATAD2 to facilitate retinoblastoma progression via miR-655-3p
  107. Development and validation of a nomogram for predicting severity in patients with hemorrhagic fever with renal syndrome: A retrospective study
  108. Analysis of COVID-19 outbreak origin in China in 2019 using differentiation method for unusual epidemiological events
  109. Laparoscopic versus open major liver resection for hepatocellular carcinoma: A case-matched analysis of short- and long-term outcomes
  110. Travelers’ vaccines and their adverse events in Nara, Japan
  111. Association between Tfh and PGA in children with Henoch–Schönlein purpura
  112. Can exchange transfusion be replaced by double-LED phototherapy?
  113. circ_0005962 functions as an oncogene to aggravate NSCLC progression
  114. Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells
  115. Serum intact fibroblast growth factor 23 in healthy paediatric population
  116. Algorithm of rational approach to reconstruction in Fournier’s disease
  117. A meta-analysis of exosome in the treatment of spinal cord injury
  118. Src-1 and SP2 promote the proliferation and epithelial–mesenchymal transition of nasopharyngeal carcinoma
  119. Dexmedetomidine may decrease the bupivacaine toxicity to heart
  120. Hypoxia stimulates the migration and invasion of osteosarcoma via up-regulating the NUSAP1 expression
  121. Long noncoding RNA XIST knockdown relieves the injury of microglia cells after spinal cord injury by sponging miR-219-5p
  122. External fixation via the anterior inferior iliac spine for proximal femoral fractures in young patients
  123. miR-128-3p reduced acute lung injury induced by sepsis via targeting PEL12
  124. HAGLR promotes neuron differentiation through the miR-130a-3p-MeCP2 axis
  125. Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient’s prognosis
  126. Cell population data in identifying active tuberculosis and community-acquired pneumonia
  127. Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression
  128. Mean platelet volume and red blood cell distribution width is associated with prognosis in premature neonates with sepsis
  129. 3D-printed porous scaffold promotes osteogenic differentiation of hADMSCs
  130. Association of gene polymorphisms with women urinary incontinence
  131. Influence of COVID-19 pandemic on stress levels of urologic patients
  132. miR-496 inhibits proliferation via LYN and AKT pathway in gastric cancer
  133. miR-519d downregulates LEP expression to inhibit preeclampsia development
  134. Comparison of single- and triple-port VATS for lung cancer: A meta-analysis
  135. Fluorescent light energy modulates healing in skin grafted mouse model
  136. Silencing CDK6-AS1 inhibits LPS-induced inflammatory damage in HK-2 cells
  137. Predictive effect of DCE-MRI and DWI in brain metastases from NSCLC
  138. Severe postoperative hyperbilirubinemia in congenital heart disease
  139. Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway
  140. Clinical factors predicting ureteral stent failure in patients with external ureteral compression
  141. Novel H2S donor proglumide-ADT-OH protects HUVECs from ox-LDL-induced injury through NF-κB and JAK/SATA pathway
  142. Triple-Endobutton and clavicular hook: A propensity score matching analysis
  143. Long noncoding RNA MIAT inhibits the progression of diabetic nephropathy and the activation of NF-κB pathway in high glucose-treated renal tubular epithelial cells by the miR-182-5p/GPRC5A axis
  144. Serum exosomal miR-122-5p, GAS, and PGR in the non-invasive diagnosis of CAG
  145. miR-513b-5p inhibits the proliferation and promotes apoptosis of retinoblastoma cells by targeting TRIB1
  146. Fer exacerbates renal fibrosis and can be targeted by miR-29c-3p
  147. The diagnostic and prognostic value of miR-92a in gastric cancer: A systematic review and meta-analysis
  148. Prognostic value of α2δ1 in hypopharyngeal carcinoma: A retrospective study
  149. No significant benefit of moderate-dose vitamin C on severe COVID-19 cases
  150. circ_0000467 promotes the proliferation, metastasis, and angiogenesis in colorectal cancer cells through regulating KLF12 expression by sponging miR-4766-5p
  151. Downregulation of RAB7 and Caveolin-1 increases MMP-2 activity in renal tubular epithelial cells under hypoxic conditions
  152. Educational program for orthopedic surgeons’ influences for osteoporosis
  153. Expression and function analysis of CRABP2 and FABP5, and their ratio in esophageal squamous cell carcinoma
  154. GJA1 promotes hepatocellular carcinoma progression by mediating TGF-β-induced activation and the epithelial–mesenchymal transition of hepatic stellate cells
  155. lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression
  156. Anticoagulation is the answer in treating noncritical COVID-19 patients
  157. Effect of late-onset hemorrhagic cystitis on PFS after haplo-PBSCT
  158. Comparison of Dako HercepTest and Ventana PATHWAY anti-HER2 (4B5) tests and their correlation with silver in situ hybridization in lung adenocarcinoma
  159. VSTM1 regulates monocyte/macrophage function via the NF-κB signaling pathway
  160. Comparison of vaginal birth outcomes in midwifery-led versus physician-led setting: A propensity score-matched analysis
  161. Treatment of osteoporosis with teriparatide: The Slovenian experience
  162. New targets of morphine postconditioning protection of the myocardium in ischemia/reperfusion injury: Involvement of HSP90/Akt and C5a/NF-κB
  163. Superenhancer–transcription factor regulatory network in malignant tumors
  164. β-Cell function is associated with osteosarcopenia in middle-aged and older nonobese patients with type 2 diabetes: A cross-sectional study
  165. Clinical features of atypical tuberculosis mimicking bacterial pneumonia
  166. Proteoglycan-depleted regions of annular injury promote nerve ingrowth in a rabbit disc degeneration model
  167. Effect of electromagnetic field on abortion: A systematic review and meta-analysis
  168. miR-150-5p affects AS plaque with ASMC proliferation and migration by STAT1
  169. MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p
  170. Effects of remifentanil and propofol on distant organ lung injury in an ischemia–reperfusion model
  171. miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway
  172. Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
  173. MitoQ inhibits hepatic stellate cell activation and liver fibrosis by enhancing PINK1/parkin-mediated mitophagy
  174. Dissecting role of founder mutation p.V727M in GNE in Indian HIBM cohort
  175. circATP2A2 promotes osteosarcoma progression by upregulating MYH9
  176. Prognostic role of oxytocin receptor in colon adenocarcinoma
  177. Review Articles
  178. The function of non-coding RNAs in idiopathic pulmonary fibrosis
  179. Efficacy and safety of therapeutic plasma exchange in stiff person syndrome
  180. Role of cesarean section in the development of neonatal gut microbiota: A systematic review
  181. Small cell lung cancer transformation during antitumor therapies: A systematic review
  182. Research progress of gut microbiota and frailty syndrome
  183. Recommendations for outpatient activity in COVID-19 pandemic
  184. Rapid Communication
  185. Disparity in clinical characteristics between 2019 novel coronavirus pneumonia and leptospirosis
  186. Use of microspheres in embolization for unruptured renal angiomyolipomas
  187. COVID-19 cases with delayed absorption of lung lesion
  188. A triple combination of treatments on moderate COVID-19
  189. Social networks and eating disorders during the Covid-19 pandemic
  190. Letter
  191. COVID-19, WHO guidelines, pedagogy, and respite
  192. Inflammatory factors in alveolar lavage fluid from severe COVID-19 pneumonia: PCT and IL-6 in epithelial lining fluid
  193. COVID-19: Lessons from Norway tragedy must be considered in vaccine rollout planning in least developed/developing countries
  194. What is the role of plasma cell in the lamina propria of terminal ileum in Good’s syndrome patient?
  195. Case Report
  196. Rivaroxaban triggered multifocal intratumoral hemorrhage of the cabozantinib-treated diffuse brain metastases: A case report and review of literature
  197. CTU findings of duplex kidney in kidney: A rare duplicated renal malformation
  198. Synchronous primary malignancy of colon cancer and mantle cell lymphoma: A case report
  199. Sonazoid-enhanced ultrasonography and pathologic characters of CD68 positive cell in primary hepatic perivascular epithelioid cell tumors: A case report and literature review
  200. Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
  201. Pulmonary parenchymal involvement caused by Tropheryma whipplei
  202. Mediastinal mixed germ cell tumor: A case report and literature review
  203. Ovarian female adnexal tumor of probable Wolffian origin – Case report
  204. Rare paratesticular aggressive angiomyxoma mimicking an epididymal tumor in an 82-year-old man: Case report
  205. Perimenopausal giant hydatidiform mole complicated with preeclampsia and hyperthyroidism: A case report and literature review
  206. Primary orbital ganglioneuroblastoma: A case report
  207. Primary aortic intimal sarcoma masquerading as intramural hematoma
  208. Sustained false-positive results for hepatitis A virus immunoglobulin M: A case report and literature review
  209. Peritoneal loose body presenting as a hepatic mass: A case report and review of the literature
  210. Chondroblastoma of mandibular condyle: Case report and literature review
  211. Trauma-induced complete pacemaker lead fracture 8 months prior to hospitalization: A case report
  212. Primary intradural extramedullary extraosseous Ewing’s sarcoma/peripheral primitive neuroectodermal tumor (PIEES/PNET) of the thoracolumbar spine: A case report and literature review
  213. Computer-assisted preoperative planning of reduction of and osteosynthesis of scapular fracture: A case report
  214. High quality of 58-month life in lung cancer patient with brain metastases sequentially treated with gefitinib and osimertinib
  215. Rapid response of locally advanced oral squamous cell carcinoma to apatinib: A case report
  216. Retrieval of intrarenal coiled and ruptured guidewire by retrograde intrarenal surgery: A case report and literature review
  217. Usage of intermingled skin allografts and autografts in a senior patient with major burn injury
  218. Retraction
  219. Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
  220. Special Issue Computational Intelligence Methodologies Meets Recurrent Cancers - Part I
  221. An artificial immune system with bootstrap sampling for the diagnosis of recurrent endometrial cancers
  222. Breast cancer recurrence prediction with ensemble methods and cost-sensitive learning
Downloaded on 15.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2021-0210/html
Scroll to top button